APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nitinol Revascularization Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nitinol Revascularization Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchNitinol Revascularization Device Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitinol Revascularization Device Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Nitinol Revascularization Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitinol Revascularization Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitinol Revascularization Device Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Nitinol Revascularization Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nitinol Revascularization Device include Acandis GmbH, Balt Group, Furukawa Techno Material, Johnson & Johnson MedTech, Penumbra, Rapid Medical, Stryker, Guichuangtongqiao Medical and Hemu Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nitinol Revascularization Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nitinol Revascularization Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nitinol Revascularization Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nitinol Revascularization Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Nitinol Revascularization Device Segment by Company

Acandis GmbH

Balt Group

Furukawa Techno Material

Johnson & Johnson MedTech

Penumbra

Rapid Medical

Stryker

Guichuangtongqiao Medical

Hemu Biotech

Jianshi Medical

Medtronic

Sinoshenchang Medical

Suzhou Zhongtian Medical

Micro-Port Shentong Medical

Xinkainuo Medical

Xinwei Medical

Nitinol Revascularization Device Segment by Type

Diameter 6MM

Diameter 4MM

Diameter 3MM

Other

Nitinol Revascularization Device Segment by Application

Hospital

Clinic

Other

Nitinol Revascularization Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol Revascularization Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitinol Revascularization Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol Revascularization Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nitinol Revascularization Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nitinol Revascularization Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nitinol Revascularization Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nitinol Revascularization Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nitinol Revascularization Device Industry Trends Table 2. Nitinol Revascularization Device Industry Drivers Table 3. Nitinol Revascularization Device Industry Opportunities and Challenges Table 4. Nitinol Revascularization Device Industry Restraints Table 5. Global Nitinol Revascularization Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nitinol Revascularization Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nitinol Revascularization Device Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Nitinol Revascularization Device Sales Market Share by Manufacturers Table 9. Global Nitinol Revascularization Device Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Nitinol Revascularization Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nitinol Revascularization Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nitinol Revascularization Device Manufacturers, Product Type & Application Table 13. Global Nitinol Revascularization Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nitinol Revascularization Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Diameter 6MM Table 17. Major Manufacturers of Diameter 4MM Table 18. Major Manufacturers of Diameter 3MM Table 19. Major Manufacturers of Other Table 20. Global Nitinol Revascularization Device Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Nitinol Revascularization Device Sales by Type (2021-2026) & (K Units) Table 22. Global Nitinol Revascularization Device Sales by Type (2027-2032) & (K Units) Table 23. Global Nitinol Revascularization Device Sales Market Share by Type (2021-2026) Table 24. Global Nitinol Revascularization Device Sales Market Share by Type (2027-2032) Table 25. Global Nitinol Revascularization Device Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Nitinol Revascularization Device Revenue by Type (2021-2026) & (K Units) Table 27. Global Nitinol Revascularization Device Revenue by Type (2027-2032) & (K Units) Table 28. Global Nitinol Revascularization Device Revenue Market Share by Type (2021-2026) Table 29. Global Nitinol Revascularization Device Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Other Table 33. Global Nitinol Revascularization Device Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Nitinol Revascularization Device Sales by Application (2021-2026) & (K Units) Table 35. Global Nitinol Revascularization Device Sales by Application (2027-2032) & (K Units) Table 36. Global Nitinol Revascularization Device Sales Market Share by Application (2021-2026) Table 37. Global Nitinol Revascularization Device Sales Market Share by Application (2027-2032) Table 38. Global Nitinol Revascularization Device Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Nitinol Revascularization Device Revenue by Application (2021-2026) & (K Units) Table 40. Global Nitinol Revascularization Device Revenue by Application (2027-2032) & (K Units) Table 41. Global Nitinol Revascularization Device Revenue Market Share by Application (2021-2026) Table 42. Global Nitinol Revascularization Device Revenue Market Share by Application (2027-2032) Table 43. Global Nitinol Revascularization Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Nitinol Revascularization Device Sales by Region (2021-2026) & (K Units) Table 45. Global Nitinol Revascularization Device Sales Market Share by Region (2021-2026) Table 46. Global Nitinol Revascularization Device Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Nitinol Revascularization Device Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 50. North America Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 51. Europe Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 53. Europe Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 60. Global Nitinol Revascularization Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Nitinol Revascularization Device Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Nitinol Revascularization Device Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Nitinol Revascularization Device Revenue Market Share by Region (2021-2026) Table 64. Global Nitinol Revascularization Device Revenue Market Share by Region (2027-2032) Table 65. Acandis GmbH Company Information Table 66. Acandis GmbH Business Overview Table 67. Acandis GmbH Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Acandis GmbH Nitinol Revascularization Device Product Portfolio Table 69. Acandis GmbH Recent Development Table 70. Balt Group Company Information Table 71. Balt Group Business Overview Table 72. Balt Group Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Balt Group Nitinol Revascularization Device Product Portfolio Table 74. Balt Group Recent Development Table 75. Furukawa Techno Material Company Information Table 76. Furukawa Techno Material Business Overview Table 77. Furukawa Techno Material Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Furukawa Techno Material Nitinol Revascularization Device Product Portfolio Table 79. Furukawa Techno Material Recent Development Table 80. Johnson & Johnson MedTech Company Information Table 81. Johnson & Johnson MedTech Business Overview Table 82. Johnson & Johnson MedTech Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio Table 84. Johnson & Johnson MedTech Recent Development Table 85. Penumbra Company Information Table 86. Penumbra Business Overview Table 87. Penumbra Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Penumbra Nitinol Revascularization Device Product Portfolio Table 89. Penumbra Recent Development Table 90. Rapid Medical Company Information Table 91. Rapid Medical Business Overview Table 92. Rapid Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Rapid Medical Nitinol Revascularization Device Product Portfolio Table 94. Rapid Medical Recent Development Table 95. Stryker Company Information Table 96. Stryker Business Overview Table 97. Stryker Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Stryker Nitinol Revascularization Device Product Portfolio Table 99. Stryker Recent Development Table 100. Guichuangtongqiao Medical Company Information Table 101. Guichuangtongqiao Medical Business Overview Table 102. Guichuangtongqiao Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio Table 104. Guichuangtongqiao Medical Recent Development Table 105. Hemu Biotech Company Information Table 106. Hemu Biotech Business Overview Table 107. Hemu Biotech Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Hemu Biotech Nitinol Revascularization Device Product Portfolio Table 109. Hemu Biotech Recent Development Table 110. Jianshi Medical Company Information Table 111. Jianshi Medical Business Overview Table 112. Jianshi Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Jianshi Medical Nitinol Revascularization Device Product Portfolio Table 114. Jianshi Medical Recent Development Table 115. Medtronic Company Information Table 116. Medtronic Business Overview Table 117. Medtronic Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Medtronic Nitinol Revascularization Device Product Portfolio Table 119. Medtronic Recent Development Table 120. Sinoshenchang Medical Company Information Table 121. Sinoshenchang Medical Business Overview Table 122. Sinoshenchang Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio Table 124. Sinoshenchang Medical Recent Development Table 125. Suzhou Zhongtian Medical Company Information Table 126. Suzhou Zhongtian Medical Business Overview Table 127. Suzhou Zhongtian Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio Table 129. Suzhou Zhongtian Medical Recent Development Table 130. Micro-Port Shentong Medical Company Information Table 131. Micro-Port Shentong Medical Business Overview Table 132. Micro-Port Shentong Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio Table 134. Micro-Port Shentong Medical Recent Development Table 135. Xinkainuo Medical Company Information Table 136. Xinkainuo Medical Business Overview Table 137. Xinkainuo Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Xinkainuo Medical Nitinol Revascularization Device Product Portfolio Table 139. Xinkainuo Medical Recent Development Table 140. Xinwei Medical Company Information Table 141. Xinwei Medical Business Overview Table 142. Xinwei Medical Nitinol Revascularization Device Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Xinwei Medical Nitinol Revascularization Device Product Portfolio Table 144. Xinwei Medical Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Nitinol Revascularization Device Distributors List Table 148. Nitinol Revascularization Device Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Nitinol Revascularization Device Product Image Figure 2. Global Nitinol Revascularization Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nitinol Revascularization Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Nitinol Revascularization Device Sales (2021-2032) & (K Units) Figure 5. Global Nitinol Revascularization Device Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nitinol Revascularization Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Diameter 6MM Image Figure 9. Diameter 4MM Image Figure 10. Diameter 3MM Image Figure 11. Other Image Figure 12. Global Nitinol Revascularization Device Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Nitinol Revascularization Device Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Nitinol Revascularization Device Sales Market Share by Type (2021-2032) Figure 15. Global Nitinol Revascularization Device Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Nitinol Revascularization Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Nitinol Revascularization Device Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Nitinol Revascularization Device Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Nitinol Revascularization Device Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Nitinol Revascularization Device Sales Market Share by Application (2021-2032) Figure 24. Global Nitinol Revascularization Device Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Nitinol Revascularization Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Nitinol Revascularization Device Revenue Market Share by Application (2021-2032) Figure 27. North America Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 29. U.S. Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 34. Germany Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 41. China Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 49. Brazil Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Nitinol Revascularization Device Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Nitinol Revascularization Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Nitinol Revascularization Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Nitinol Revascularization Device Revenue (2021-2032) & (US$ Million) Figure 60. North America Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Nitinol Revascularization Device Revenue (2021-2032) & (US$ Million) Figure 62. Europe Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Nitinol Revascularization Device Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Nitinol Revascularization Device Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Nitinol Revascularization Device Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Nitinol Revascularization Device Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Diameter 6MM
  • Diameter 4MM
  • Diameter 3MM
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Acandis GmbH
  • Balt Group
  • Furukawa Techno Material
  • Johnson & Johnson MedTech
  • Penumbra
  • Rapid Medical
  • Stryker
  • Guichuangtongqiao Medical
  • Hemu Biotech
  • Jianshi Medical
  • Medtronic
  • Sinoshenchang Medical
  • Suzhou Zhongtian Medical
  • Micro-Port Shentong Medical
  • Xinkainuo Medical
  • Xinwei Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nitinol Revascularization Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nitinol Revascularization Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nitinol Revascularization Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nitinol Revascularization Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nitinol Revascularization Device Market Dynamics
  1. 2.1 Nitinol Revascularization Device Industry Trends
  2. 2.2 Nitinol Revascularization Device Industry Drivers
  3. 2.3 Nitinol Revascularization Device Industry Opportunities and Challenges
  4. 2.4 Nitinol Revascularization Device Industry Restraints
3 Nitinol Revascularization Device Market by Manufacturers
  1. 3.1 Global Nitinol Revascularization Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nitinol Revascularization Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nitinol Revascularization Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nitinol Revascularization Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nitinol Revascularization Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nitinol Revascularization Device Manufacturers, Product Type & Application
  7. 3.7 Global Nitinol Revascularization Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nitinol Revascularization Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nitinol Revascularization Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nitinol Revascularization Device Tier 1, Tier 2, and Tier 3
4 Nitinol Revascularization Device Market by Type
  1. 4.1 Nitinol Revascularization Device Type Introduction
  2. 4.1.1 Diameter 6MM
  3. 4.1.2 Diameter 4MM
  4. 4.1.3 Diameter 3MM
  5. 4.1.4 Other
  6. 4.2 Global Nitinol Revascularization Device Sales by Type
  7. 4.2.1 Global Nitinol Revascularization Device Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nitinol Revascularization Device Sales by Type (2021-2032)
  9. 4.2.3 Global Nitinol Revascularization Device Sales Market Share by Type (2021-2032)
  10. 4.3 Global Nitinol Revascularization Device Revenue by Type
  11. 4.3.1 Global Nitinol Revascularization Device Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Nitinol Revascularization Device Revenue by Type (2021-2032)
  13. 4.3.3 Global Nitinol Revascularization Device Revenue Market Share by Type (2021-2032)
5 Nitinol Revascularization Device Market by Application
  1. 5.1 Nitinol Revascularization Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Nitinol Revascularization Device Sales by Application
  6. 5.2.1 Global Nitinol Revascularization Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nitinol Revascularization Device Sales by Application (2021-2032)
  8. 5.2.3 Global Nitinol Revascularization Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Nitinol Revascularization Device Revenue by Application
  10. 5.3.1 Global Nitinol Revascularization Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nitinol Revascularization Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Nitinol Revascularization Device Revenue Market Share by Application (2021-2032)
6 Global Nitinol Revascularization Device Sales by Region
  1. 6.1 Global Nitinol Revascularization Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nitinol Revascularization Device Sales by Region (2021-2032)
  3. 6.2.1 Global Nitinol Revascularization Device Sales by Region (2021-2026)
  4. 6.2.2 Global Nitinol Revascularization Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nitinol Revascularization Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nitinol Revascularization Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nitinol Revascularization Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nitinol Revascularization Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nitinol Revascularization Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nitinol Revascularization Device Revenue by Region
  1. 7.1 Global Nitinol Revascularization Device Revenue by Region
  2. 7.1.1 Global Nitinol Revascularization Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nitinol Revascularization Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Nitinol Revascularization Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Nitinol Revascularization Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nitinol Revascularization Device Revenue (2021-2032)
  8. 7.2.2 North America Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nitinol Revascularization Device Revenue (2021-2032)
  11. 7.3.2 Europe Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nitinol Revascularization Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nitinol Revascularization Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nitinol Revascularization Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Acandis GmbH
  2. 8.1.1 Acandis GmbH Company Information
  3. 8.1.2 Acandis GmbH Business Overview
  4. 8.1.3 Acandis GmbH Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Acandis GmbH Nitinol Revascularization Device Product Portfolio
  6. 8.1.5 Acandis GmbH Recent Developments
  7. 8.2 Balt Group
  8. 8.2.1 Balt Group Company Information
  9. 8.2.2 Balt Group Business Overview
  10. 8.2.3 Balt Group Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Balt Group Nitinol Revascularization Device Product Portfolio
  12. 8.2.5 Balt Group Recent Developments
  13. 8.3 Furukawa Techno Material
  14. 8.3.1 Furukawa Techno Material Company Information
  15. 8.3.2 Furukawa Techno Material Business Overview
  16. 8.3.3 Furukawa Techno Material Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Furukawa Techno Material Nitinol Revascularization Device Product Portfolio
  18. 8.3.5 Furukawa Techno Material Recent Developments
  19. 8.4 Johnson & Johnson MedTech
  20. 8.4.1 Johnson & Johnson MedTech Company Information
  21. 8.4.2 Johnson & Johnson MedTech Business Overview
  22. 8.4.3 Johnson & Johnson MedTech Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio
  24. 8.4.5 Johnson & Johnson MedTech Recent Developments
  25. 8.5 Penumbra
  26. 8.5.1 Penumbra Company Information
  27. 8.5.2 Penumbra Business Overview
  28. 8.5.3 Penumbra Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Penumbra Nitinol Revascularization Device Product Portfolio
  30. 8.5.5 Penumbra Recent Developments
  31. 8.6 Rapid Medical
  32. 8.6.1 Rapid Medical Company Information
  33. 8.6.2 Rapid Medical Business Overview
  34. 8.6.3 Rapid Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rapid Medical Nitinol Revascularization Device Product Portfolio
  36. 8.6.5 Rapid Medical Recent Developments
  37. 8.7 Stryker
  38. 8.7.1 Stryker Company Information
  39. 8.7.2 Stryker Business Overview
  40. 8.7.3 Stryker Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Stryker Nitinol Revascularization Device Product Portfolio
  42. 8.7.5 Stryker Recent Developments
  43. 8.8 Guichuangtongqiao Medical
  44. 8.8.1 Guichuangtongqiao Medical Company Information
  45. 8.8.2 Guichuangtongqiao Medical Business Overview
  46. 8.8.3 Guichuangtongqiao Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio
  48. 8.8.5 Guichuangtongqiao Medical Recent Developments
  49. 8.9 Hemu Biotech
  50. 8.9.1 Hemu Biotech Company Information
  51. 8.9.2 Hemu Biotech Business Overview
  52. 8.9.3 Hemu Biotech Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hemu Biotech Nitinol Revascularization Device Product Portfolio
  54. 8.9.5 Hemu Biotech Recent Developments
  55. 8.10 Jianshi Medical
  56. 8.10.1 Jianshi Medical Company Information
  57. 8.10.2 Jianshi Medical Business Overview
  58. 8.10.3 Jianshi Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jianshi Medical Nitinol Revascularization Device Product Portfolio
  60. 8.10.5 Jianshi Medical Recent Developments
  61. 8.11 Medtronic
  62. 8.11.1 Medtronic Company Information
  63. 8.11.2 Medtronic Business Overview
  64. 8.11.3 Medtronic Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medtronic Nitinol Revascularization Device Product Portfolio
  66. 8.11.5 Medtronic Recent Developments
  67. 8.12 Sinoshenchang Medical
  68. 8.12.1 Sinoshenchang Medical Company Information
  69. 8.12.2 Sinoshenchang Medical Business Overview
  70. 8.12.3 Sinoshenchang Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio
  72. 8.12.5 Sinoshenchang Medical Recent Developments
  73. 8.13 Suzhou Zhongtian Medical
  74. 8.13.1 Suzhou Zhongtian Medical Company Information
  75. 8.13.2 Suzhou Zhongtian Medical Business Overview
  76. 8.13.3 Suzhou Zhongtian Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio
  78. 8.13.5 Suzhou Zhongtian Medical Recent Developments
  79. 8.14 Micro-Port Shentong Medical
  80. 8.14.1 Micro-Port Shentong Medical Company Information
  81. 8.14.2 Micro-Port Shentong Medical Business Overview
  82. 8.14.3 Micro-Port Shentong Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio
  84. 8.14.5 Micro-Port Shentong Medical Recent Developments
  85. 8.15 Xinkainuo Medical
  86. 8.15.1 Xinkainuo Medical Company Information
  87. 8.15.2 Xinkainuo Medical Business Overview
  88. 8.15.3 Xinkainuo Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Xinkainuo Medical Nitinol Revascularization Device Product Portfolio
  90. 8.15.5 Xinkainuo Medical Recent Developments
  91. 8.16 Xinwei Medical
  92. 8.16.1 Xinwei Medical Company Information
  93. 8.16.2 Xinwei Medical Business Overview
  94. 8.16.3 Xinwei Medical Nitinol Revascularization Device Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Xinwei Medical Nitinol Revascularization Device Product Portfolio
  96. 8.16.5 Xinwei Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nitinol Revascularization Device Value Chain Analysis
  2. 9.1.1 Nitinol Revascularization Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nitinol Revascularization Device Production Mode & Process
  6. 9.2 Nitinol Revascularization Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nitinol Revascularization Device Distributors
  9. 9.2.3 Nitinol Revascularization Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst